3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
23
Recurrence
3
Neoplasms, Plasma Cell
2
Lymphoma
2
beta-Thalassemia
1
Thalassemia
1
Sarcoma, Myeloid
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Neoplasms
1
Neoplasm Metastasis
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
HIV Infections
1
Carcinoma, Non-Small-Cell Lung
1
Anemia, Sickle Cell
1
Interventions
Carboplatin
12
atezolizumab
11
Etoposide
10
PM 01183
8
durvalumab
6
Topotecan
6
Specimen Handling
4
pembrolizumab
3
Magnetic Resonance Spectroscopy
3
AMG 757
3
Paclitaxel
2
Irinotecan
2
Injections
2
Drug Therapy
2
Cisplatin
2
Biopsy
2
trastuzumab deruxtecan
1
toripalimab
1
olaparib
1
lenvatinib
1
futibatinib
1
fludarabine
1
enzalutamide
1
cabozantinib
1
berzosertib
1
avelumab
1
arginine decarboxylase
1
amrubicin
1
Vaccines
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Bortezomib
×
30 days
×
Clear all
No trials found.